Scarica l'app Stockscreener
1.20
4.35%
0.05
Dopo l'orario di chiusura:
1.20
Precedente Chiudi:
$1.15
Aprire:
$1.14
Volume 24 ore:
1.57M
Relative Volume:
1.17
Capitalizzazione di mercato:
$458.39M
Reddito:
$106.34M
Utile/perdita netta:
$-74.66M
Rapporto P/E:
-1.2632
EPS:
-0.95
Flusso di cassa netto:
$-46.12M
1 W Prestazione:
-15.49%
1M Prestazione:
-7.69%
6M Prestazione:
+8.11%
1 anno Prestazione:
-38.78%
Intervallo 1D:
$1.13
$1.25
Intervallo di 1 settimana:
$1.12
$1.43
Portata 52W:
$0.92
$2.32
Standard Biotools Inc Stock (LAB) Company Profile
Nome
Standard Biotools Inc
Settore
Industria
Telefono
(650) 266-6000
Indirizzo
2 TOWER PLACE, SOUTH SAN FRANCISCO
Confronta LAB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LAB
Standard Biotools Inc
|
1.20 | 439.29M | 106.34M | -74.66M | -46.12M | -0.95 |
|
ABT
Abbott Laboratories
|
123.62 | 216.79B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
100.72 | 149.02B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
356.24 | 141.06B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
90.70 | 116.68B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
82.45 | 49.01B | 5.88B | 1.34B | 577.90M | 2.3455 |
Standard Biotools Inc Stock (LAB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-13 | Downgrade | TD Cowen | Buy → Hold |
| 2025-02-27 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-04-16 | Iniziato | TD Cowen | Buy |
| 2024-04-04 | Iniziato | Jefferies | Buy |
| 2023-07-12 | Iniziato | KeyBanc Capital Markets | Overweight |
Standard Biotools Inc Borsa (LAB) Ultime notizie
Understanding Standard BioTools Inc.’s price movementM&A Rumor & Pattern Based Trade Signal System - newser.com
Is Mahasagar Travels Limited Stock a Core Holding or a Speculative PlayCup and Handle Formations & Technical + Fundamental = Smarter Investing - earlytimes.in
Standard BioTools Inc. recovery potential after sell off2025 Geopolitical Influence & Long Hold Capital Preservation Plans - newser.com
Why Standard BioTools Inc. (FLB) stock is upgraded to buy2025 Investor Takeaways & Expert Approved Momentum Ideas - newser.com
Why Standard BioTools Inc. (FLB) stock gets analyst attentionWeekly Earnings Recap & Stepwise Swing Trade Plans - newser.com
Can momentum traders help lift Standard BioTools Inc.July 2025 Recap & Capital Efficiency Focused Ideas - newser.com
Analyzing net buyer seller activity in Standard BioTools Inc.Portfolio Update Summary & Risk Managed Trade Strategies - newser.com
Top chart patterns to watch in Standard BioTools Inc.Exit Point & Weekly Watchlist for Hot Stocks - newser.com
Is Standard BioTools Inc. stock cheap compared to fundamentalsQuarterly Portfolio Review & Risk Controlled Daily Plans - newser.com
Standard BioTools (NASDAQ:LAB) Stock Price Down 6.7%Time to Sell? - MarketBeat
Standard BioTools' (LAB) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
Standard Biotools Inc Azioni (LAB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.34%
14.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):